Menu
Back to User profile » Dr Nobuhiro Kanaji
Papers published by Dr Nobuhiro Kanaji:
Clinical features of patients with lung cancer accompanied by thromboembolism or disseminated intravascular coagulation
Kanaji N, Mizoguchi H, Inoue T, Tadokoro A, Watanabe N, Ishii T, Tojo Y, Yamaguchi M, Kadowaki N
Therapeutics and Clinical Risk Management 2018, 14:1361-1368
Published Date: 1 August 2018
Higher susceptibility of NOD/LtSz-scid Il2rg-/- NSG mice to xenotransplanted lung cancer cell lines
Kanaji N, Tadokoro A, Susaki K, Yokokura S, Ohmichi K, Haba R, Watanabe N, Bandoh S, Ishii T, Dobashi H, Matsunaga T
Cancer Management and Research 2014, 6:431-436
Published Date: 21 October 2014
Anti-inflammatory effects of budesonide in human lung fibroblasts are independent of histone deacetylase 2
Wang X, Nelson A, Weiler ZM, Patil A, Sato T, Kanaji N, Nakanishi M, Michalski J, Farid M, Basma H, LeVan TD, Miller-Larsson A, Wieslander E, Muller KC, Holz O, Magnussen H, Rabe KF, Liu X, Rennard SI
Journal of Inflammation Research 2013, 6:109-119
Published Date: 20 August 2013
Inflammatory cytokines regulate endothelial cell survival and tissue repair functions via NF-κB signaling
Kanaji N, Sato T, Nelson A, Wang X, Li Y, Kim M, Nakanishi M, Basma H, Michalski J, Farid M, Chandler M, Pease W, Patil A, Rennard SI, Liu X
Journal of Inflammation Research 2011, 4:127-138
Published Date: 15 September 2011